TCL Archive A Message From NCI: “We Deeply Regret The Need To Eliminate This Program.” AP4 Applicants And Corporate Partners Spent Years, Money, Before NCI Pulled The Plug On Novel Public-Private Partnerships. Von Eschenbach Called AP4 “A New Paradigm” For Drug Development. NCI Executive Committee “Prioritized” Programs. April 21, 2006
TCL Archive Vaccine and LDCT Pretreatment Can Help PDACs Become Vulnerable to Immunotherapy June 27, 2014
TCL Archive In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes May 7, 1993
TCL Archive FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners November 7, 1997